M. Baldus
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
- Genetics 8
- Chronic Lymphocytic Leukemia Research 4
- Hemoglobinopathies and Related Disorders 3
-
- Acute Myeloid Leukemia Research 5
- Iron Metabolism and Disorders 2
- Co-authors
- Corinna Baust (2 shared papers)Heyko Skladny (2 shared papers)Dieter Buchheidt (2 shared papers)Rüediger Hehlmann (1 shared paper)T. Suedhoff (1 shared paper)J. Ritter (1 shared paper)Wolfgang Seifarth (1 shared paper)Rüdiger Hehlmann (1 shared paper)
- Journals
- British Journal of Haematology (2 papers)Clinical Infectious Diseases (1 paper)Journal of Clinical Oncology (1 paper)Anti-Cancer Drugs (1 paper)Annals of Hematology (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
M. Baldus
15 papers receiving 312 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 180
- Hematology 79
- Small Animals 43
- Epidemiology 179
- Cell Biology 54
Countries citing papers authored by M. Baldus
This map shows the geographic impact of M. Baldus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Baldus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Baldus more than expected).
Fields of papers citing papers by M. Baldus
This network shows the impact of papers produced by M. Baldus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Baldus. The network helps show where M. Baldus may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Baldus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 117 | |
| 2 | 2002 | 68 | |
| 3 | 1998 | 44 | |
| 4 | 2000 | 35 | |
| 5 | 2003 | 11 | |
| 6 | 2008 | 10 | |
| 7 | 1999 | 8 | |
| 8 | Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients. | 1996 | 8 |
| 9 | Serum level changes of endogenous and postheparin diamine oxidase (histaminase) in clinical and experimental hepatitis. | 1976 | 6 |
| 10 | 1994 | 4 | |
| 11 | Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients. | 1998 | 4 |
| 12 | 1994 | 2 | |
| 13 | 2008 | 1 | |
| 14 | 1995 | 1 | |
| 15 | [Suramin--a new therapeutic principle in the treatment of metastatic adrenal gland cancer]. | 1990 | 1 |
| 16 | 1992 | 0 | |
| 17 | 1997 | 0 |
About M. Baldus
M. Baldus is a scholar working on Genetics, Hematology, Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology, having authored 17 papers that have together received 320 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Iron Metabolism and Disorders (2 papers), Fungal Infections and Studies (2 papers), Antifungal resistance and susceptibility (2 papers), Metabolism and Genetic Disorders (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Infectious Diseases (180 citations), Hematology (79 citations), Small Animals (43 citations), Epidemiology (179 citations) and Cell Biology (54 citations). M. Baldus has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Corinna Baust, Heyko Skladny, Dieter Buchheidt, Rüediger Hehlmann, T. Suedhoff, J. Ritter, Wolfgang Seifarth, Rüdiger Hehlmann, Susanne Bräuninger and M. Uppenkamp. Their work appears in journals such as British Journal of Haematology, Clinical Infectious Diseases, Journal of Clinical Oncology, Anti-Cancer Drugs and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.